Dividend Details

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE4696.60-37.7 (-0.8 %)
PREV CLOSE ( ) 4734.30
OPEN PRICE ( ) 4730.95
BID PRICE (QTY) 4697.30 (7)
OFFER PRICE (QTY) 4703.95 (3)
VOLUME 2073
TODAY'S LOW / HIGH ( )4655.00 4738.95
52 WK LOW / HIGH ( )3211.05 5519.1
NSE4701.00-33.3 (-0.7 %)
PREV CLOSE( ) 4734.30
OPEN PRICE ( ) 4740.00
BID PRICE (QTY) 4699.10 (9)
OFFER PRICE (QTY) 4701.00 (7)
VOLUME 222895
TODAY'S LOW / HIGH( ) 4651.40 4749.15
52 WK LOW / HIGH ( )3186.3 5520

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.